The balance between two isoforms of LEF-1 regulates colon carcinoma growth
Open Access
- 28 May 2012
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 12 (1) , 53
Abstract
Colon cancer is one of the most aggressive human malignancies, with a very poor prognosis. Although it has been suggested that different isoforms of the lymphoid enhancer factor (LEF-1) have opposing biological activities, the biological outcome of aberrant LEF-1 activation in colon cancer is still unclear. The aim of this study was to evaluate the effect of the different LEF-1 phenotypes on the growth of colon carcinoma cell lines. A deeper understanding of these processes might improve the targeted therapies for colon cancer by regulating the expression of LEF-1.Keywords
This publication has 33 references indexed in Scilit:
- The SDF-1/CXCR4 Axis Is a Novel Driver of Vascular Development of the GlomerulusJournal of the American Society of Nephrology, 2009
- CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinomaCancer Letters, 2004
- β-catenin–sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancerNature Genetics, 2001
- The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicingNucleic Acids Research, 2000
- Modulation of Transcriptional Regulation by LEF-1 in Response to Wnt-1 Signaling and Association with β-CateninMolecular and Cellular Biology, 1998
- Redundant Regulation of T Cell Differentiation and TCRα Gene Expression by the Transcription Factors LEF-1 and TCF-1Immunity, 1998
- Induction of a β-catenin-LEF-1 complex by wnt-1 and transforming mutants of β-cateninOncogene, 1997
- ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function.Genes & Development, 1997
- Extensive Alternative Splicing and Dual Promoter Usage Generate Tcf-1 Protein Isoforms with Differential Transcription Control PropertiesMolecular and Cellular Biology, 1996
- DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1.Genes & Development, 1991